Synchronous mineralization of three aqueous non-steroidal anti-inflammatory drugs in electrochemical advanced oxidation process

Electrochemical degradation performances of three non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen (ACT), aspirin (ASP) and ibuprofen (IBP), were investigated and compared in their alone and mixture conditions using Ti/SnO2-Sb/La-PbO2. The pseudo-first-order degradation kinetics (k) order was k(IBP-A) (0.110 min(-1)) > k(ASP-A) (0.092 min(-1)) > k(ACT-A) (0.066 min(-1)) in their alone condition, while that was k(ACT-M) (0.088 min(-1)) > k(ASP-M) (0.063 min(-1)) > k(IBP-M) (0.057 min(-1)) in their mixture condition. The (OH)-O-center dot apparent production rate constant of 5.23 mmol L-1 min(-1) m(-2) and an electrical energy per order (E-EO) value of 6.55 Wh/L could ensure the synchronous degradation of the NSAIDs mixture. The mineralization efficiency of NSAIDs mixture was 86.9% at 240 min with a mineralization current efficiency of 1.67%. Acetic acid and oxalic acid were the main products in the mineralization process for the both conditions. In the mixture condition, there were higher k values at lower initial concentrations and higher current density, while the presence of carbonate and humic acid inhibited their degradation. The results indicated electrochemical advanced oxidation process can effectively and synchronously mineralize NSAIDs mixture in wastewater. (C) 2022 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.

Automated summary

The electrochemical degradation performances of three non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen (ACT), aspirin (ASP), and ibuprofen (IBP), were investigated and compared in their alone and mixture conditions. The results showed that the synchronous degradation of the NSAIDs mixture can be effectively achieved through the electrochemical advanced oxidation process.